Effect of a pneumococcal whole cell vaccine on influenza A-induced pneumococcal otitis media in infant mice

被引:4
|
作者
Manning, Jayne [1 ,2 ]
Dunne, Eileen M. [1 ,3 ]
Wang, Nancy [2 ]
Pedersen, John S. [4 ]
Ogier, Jacqueline M. [3 ,5 ]
Burt, Rachel A. [3 ,5 ]
Mulholland, E. Kim [1 ,6 ]
Robins-Browne, Roy M. [2 ,7 ]
Malley, Richard [8 ]
Wijburg, Odilia L. [1 ,2 ]
Satzke, Catherine [1 ,2 ,3 ]
机构
[1] Royal Childrens Hosp, Murdoch Childrens Res Inst, Pneumococcal Res, Parkville, Vic, Australia
[2] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia
[3] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Melbourne, Vic, Australia
[4] TissuPath Pty Ltd, Hawthorn, Vic, Australia
[5] Royal Childrens Hosp, Murdoch Childrens Res Inst, Neurogenet, Parkville, Vic, Australia
[6] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England
[7] Murdoch Childrens Res Inst, Infect Dis, Parkville, Vic, Australia
[8] Boston Childrens Hosp, Div Infect Dis, Boston, MA USA
基金
澳大利亚国家健康与医学研究理事会;
关键词
Otitis media; Streptococcus pneumoniae; Pneumococcus; Vaccine; Whole cell vaccine; Influenza A virus; Mouse model; STREPTOCOCCUS-PNEUMONIAE; MIDDLE-EAR; COLONIZATION; CHILDREN; ANTIBODY; DISEASE; PROTECTION; INFECTION; BACTERIAL; IMMUNITY;
D O I
10.1016/j.vaccine.2019.03.013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The pneumococcus remains a common cause of otitis media (OM) despite the widespread introduction of pneumococcal conjugate vaccines. In mice, a pneumococcal whole cell vaccine (WCV) induces serotype-independent protection against pneumococcal colonisation and invasive disease via T(H)17- and antibody-mediated immunity, respectively. We investigated the effect of WCV on influenza A-induced pneumococcal OM in an infant mouse model. C57BL/6 mice were immunised subcutaneously with a single dose of WCV or adjuvant at 6 days of age, infected with pneumococci (EF3030 [serotype 19F] or PMP1106 [16F]) at 12 days of age, and given influenza A virus (A/Udorn/72/307 [H3N2], IAV) at 18 days of age to induce pneumococcal OM. Pneumococcal density in middle ear and nasopharyngeal tissues was determined 6 and 12 days post-virus. Experiments were repeated in antibody (B6.mu MT-/-)- and CD4(+) T-cell-deficient mice to investigate the immune responses involved. A single dose of WCV did not prevent the development of pneumococcal OM, nor accelerate pneumococcal clearance compared with mice receiving adjuvant alone. However, WCV reduced the density of EF3030 in the middle ear at 6 days post-viral infection (p = 0.022), and the density of both isolates in the nasopharynx at 12 days post-viral infection (EF3030, p = 0.035; PMP1106, p = 0.011), compared with adjuvant alone. The reduction in density in the middle ear required antibodies and CD4(+) T cells: WCV did not reduce EF3030 middle ear density in B6.mu MT-/- mice (p = 0.35) nor in wild-type mice given anti-CD4 monoclonal antibody before and after IAV inoculation (p = 0.91); and WCV-immunised CD4(+) T cell-deficient GK1.5 mice had higher levels of EF3030 in the middle ear than their adjuvant-immunised counterparts (p = 0.044). A single subcutaneous dose of WCV reduced pneumococcal density in the middle ears of co-infected mice in one of two strains tested, but did not prevent OM from occurring in this animal model. (C) 2019 The Authors. Published by Elsevier Ltd.
引用
收藏
页码:3495 / 3504
页数:10
相关论文
共 50 条
  • [1] Pneumococcal vaccine (Prevnar) for otitis media
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2003, 45 (1153): : 27 - 28
  • [2] PNEUMOCOCCAL VACCINE IN OTITIS-MEDIA
    MAKELA, PH
    KARMA, P
    LANCET, 1981, 1 (8212): : 152 - 153
  • [3] PNEUMOCOCCAL VACCINE IN OTITIS-MEDIA
    FILICE, GA
    LANCET, 1980, 2 (8206): : 1248 - 1249
  • [4] PNEUMOCOCCAL VACCINE AND OTITIS-MEDIA
    MAKELA, PH
    HERVA, E
    SIBAKOV, M
    HENRICHSEN, J
    LUOTONEN, J
    LEINONEN, M
    TIMONEN, M
    KOSKELA, M
    PUKANDER, J
    GRONROOS, P
    PONTYNEN, S
    KARMA, P
    LANCET, 1980, 2 (8194): : 547 - 551
  • [5] Influenza-Induced Inflammation Drives Pneumococcal Otitis Media
    Short, Kirsty R.
    Reading, Patrick C.
    Brown, Lorena E.
    Pedersen, John
    Gilbertson, Brad
    Job, Emma R.
    Edenborough, Kathryn M.
    Habets, Marrit N.
    Zomer, Aldert
    Hermans, Peter W. M.
    Diavatopoulos, Dimitri A.
    Wijburg, Odilia L.
    INFECTION AND IMMUNITY, 2013, 81 (03) : 645 - 652
  • [6] Effect of conjugate pneumococcal vaccine on recurrent acute otitis media
    Esposito, S
    Principi, N
    LANCET, 2003, 362 (9389): : 1080 - 1081
  • [7] Impact of pneumococcal and influenza vaccines on otitis media
    Jenson, HB
    Baltimore, RS
    CURRENT OPINION IN PEDIATRICS, 2004, 16 (01) : 58 - 60
  • [8] PNEUMOCOCCAL VACCINE AND OTITIS-MEDIA IN INFANCY
    MAKELA, PH
    KARMA, P
    LEINONEN, MK
    BULLETIN EUROPEEN DE PHYSIOPATHOLOGIE RESPIRATOIRE-CLINICAL RESPIRATORY PHYSIOLOGY, 1983, 19 (02): : 235 - 238
  • [9] Impact of the pneumococcal conjugate vaccine on otitis media
    Fireman, B
    Black, SB
    Shinefield, HR
    Lee, J
    Lewis, E
    Ray, P
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (01) : 10 - 16
  • [10] PNEUMOCOCCAL OTITIS-MEDIA VACCINE TRIALS
    KLEIN, JO
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1989, 8 (01) : S82 - S83